Design
Review
No takes yet. Share an insight, caveat, or question.
Historical view underscores metabolic drivers in HF; leaves open validation of metabolic therapies in contemporary trials.
Herrmann et al. (1939) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: